Literature DB >> 12728167

Health effects associated with smokeless tobacco: a systematic review.

J A Critchley1, B Unal.   

Abstract

BACKGROUND: It is believed that health risks associated with smokeless tobacco (ST) use are lower than those with cigarette smoking. A systematic review was therefore carried out to summarise these risks.
METHODS: Several electronic databases were searched, supplemented by screening reference lists, smoking related websites, and contacting experts. Analytical observational studies of ST use (cohorts, case-control, cross sectional studies) with a sample size of >/=500 were included if they reported on one or more of the following outcomes (all cause mortality, oral and pharyngeal cancers, other cancers, cardiovascular diseases, dental diseases, pregnancy outcomes, surgical outcomes). Data extraction covered control of confounding, selection of cases and controls, sample size, clear definitions and measurements of the health outcome, and ST use. Selection, extraction and quality assessments were carried out by one or two independent reviewers.
RESULTS: A narrative review was carried out. Many of the studies lacked sufficient power to estimate precise risks, mainly due to the small number of ST users. Studies were often not designed to investigate ST use, and many also had major methodological limitations including poor control for cigarette smoking and imprecise measurements of exposure. Studies in India showed a substantial risk of oral or oropharyngeal cancers associated with chewing betel quid and tobacco. Studies from other regions and of other cancer types were not consistent. Few studies have adequately considered the non-cancer health effects of ST use.
CONCLUSIONS: Chewing betel quid and tobacco is associated with a substantial risk of oral cancers in India. Most recent studies from the US and Scandinavia are not statistically significant, but moderate positive associations cannot be ruled out due to lack of power. Further rigorous studies with adequate sample sizes are required, especially for cardiovascular disease.

Entities:  

Mesh:

Year:  2003        PMID: 12728167      PMCID: PMC1746661          DOI: 10.1136/thorax.58.5.435

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  94 in total

1.  A national qualitative study of tobacco use among career firefighters and department health personnel.

Authors:  Walker S C Poston; C K Haddock; Nattinee Jitnarin; Sara A Janhke
Journal:  Nicotine Tob Res       Date:  2011-12-16       Impact factor: 4.244

Review 2.  Pharmacological interventions for the treatment of smokeless tobacco use.

Authors:  Jon O Ebbert; Karl Fagerstrom
Journal:  CNS Drugs       Date:  2012-01-01       Impact factor: 5.749

3.  Evaluating the Effects of Varenicline on Craving, Withdrawal, and Affect in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Varenicline for Smokeless Tobacco Dependence in India.

Authors:  Sonali Jhanjee; Raka Jain; Veena Jain; Tina Gupta; Swati Mittal; Patricia Goelz; Robert A Schnoll
Journal:  J Psychoactive Drugs       Date:  2015-08-28

4.  LC-MS/MS Analysis of Sugars, Alditols, and Humectants in Smokeless Tobacco Products.

Authors:  Liqun Wang; Stephen Stanfill; Liza Valentin-Blasini; Clifford H Watson; Roberto Bravo Cardenas
Journal:  Beitr Tab Int       Date:  2019-06-13

Review 5.  "Not safe" is not enough: smokers have a right to know more than there is no safe tobacco product.

Authors:  L T Kozlowski; B Q Edwards
Journal:  Tob Control       Date:  2005-08       Impact factor: 7.552

6.  Public health measures to reduce smoking prevalence in the UK: how many lives could be saved?

Authors:  S Lewis; D Arnott; C Godfrey; J Britton
Journal:  Tob Control       Date:  2005-08       Impact factor: 7.552

7.  Public health implications of smokeless tobacco use as a harm reduction strategy.

Authors:  David A Savitz; Roger E Meyer; Jason M Tanzer; Sidney S Mirvish; Freddi Lewin
Journal:  Am J Public Health       Date:  2006-10-03       Impact factor: 9.308

8.  Do personality traits related to affect regulation predict other tobacco product use among young adult non-daily smokers?

Authors:  Kristin Brikmanis; Angela Petersen; Neal Doran
Journal:  Addict Behav       Date:  2017-07-10       Impact factor: 3.913

9.  Effect of smokeless tobacco products on human oral bacteria growth and viability.

Authors:  Min Liu; Jinshan Jin; Hongmiao Pan; Jinhui Feng; Carl E Cerniglia; Maocheng Yang; Huizhong Chen
Journal:  Anaerobe       Date:  2016-10-15       Impact factor: 3.331

Review 10.  Surveillance methods for identifying, characterizing, and monitoring tobacco products: potential reduced exposure products as an example.

Authors:  Richard J O'Connor; K Michael Cummings; Vaughan W Rees; Gregory N Connolly; Kaila J Norton; David Sweanor; Mark Parascandola; Dorothy K Hatsukami; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.